Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Pierian Biosciences logo — Personalised Cancer Intelligence

Pierian Biosciences

Personalised Cancer Intelligence

Founded 2008 United States Franklin, United States 9 employees Private Equity Biotechnology, Health Care +2

General Information

Company Name Pierian Biosciences
Founded Year 2008
Location United States Franklin, United States
Employees 9
Industries Biotechnology, Health Care, IT +1
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Pierian Biosciences. To contact Pierian Biosciences, visit pierianbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Pierian Biosciences

Pierian Biosciences is a Franklin, Tenn. based privately held life sciences company specializing in personalized cancer intelligence. The company's focus is on providing innovative, treatment-directing information to healthcare providers. This approach enables the design of patient-specific strategies to enhance outcomes, improve the quality of life, and reduce the cost of cancer care. Pierian Biosciences' technology revolves around the ChemoINTEL and ImmunoINTEL platforms. The company operates a laboratory in Franklin, Tenn. and has business offices in both Franklin, Tenn. and the UK. Established in 2008, Pierian Biosciences operates within the realms of biotechnology, healthcare, IT, and information technology. Currently, there is no publicly available data on the last investment or the investors involved.

Taxonomy: Precision Medicine, Cancer Intelligence, Personalized Therapy, Biologic Cancer Therapy, Immunotherapy, Treatment Decision Support, Patient-specific Strategies, Life Sciences, Oncology Innovation, Cancer Care Optimization

No funding data available for Pierian Biosciences yet.

Pierian Biosciences Alternatives & Competitors

Pierian Biosciences vs
Invitrocue
Invitrocue United States

Invitrocue Pte Ltd. | Transforming Bioanalytics

32 employees
Biotechnology, Health Care
Pierian Biosciences vs
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. United States

Targeted α-Particle Radiotherapy for Cancer

Grant
10 employees
Biotechnology, Health Care
Pierian Biosciences vs
Castle Biosciences, Inc.
Castle Biosciences, Inc. United States

Improving health through innovative tests that guide patient care

Post-IPO Equity
744 employees
Biotechnology, Health Care

FAQ About Pierian Biosciences

Personalised Cancer Intelligence
Pierian Biosciences was founded in 2008.
Pierian Biosciences is headquartered in Franklin, United States.
Pierian Biosciences operates in Biotechnology, Health Care, IT and Information Technology. Its work centres on Precision Medicine, Cancer Intelligence, Personalized Therapy and Biologic Cancer Therapy.
Pierian Biosciences has approximately 9 employees.
Top alternatives and competitors to Pierian Biosciences include Invitrocue, Viewpoint Molecular Targeting, Inc., Castle Biosciences, Inc., Chimera Bioengineering, Cvergenx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pierian Biosciences and Invitrocue are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pierian Biosciences, https://bouncewatch.com/company/pierian-biosciences, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes